ONGOING AND UPCOMING TRIALS

Viventis is actively involved in pioneering clinical trials aimed at validating the efficacy of AI-discovered drugs and gene-based therapies. Our current trials focus on:

• AI-powered drug discovery for various cancer types

• CAR-T therapy advancements for leukemia patients

• Personalized mRNA treatments for solid tumors

ELIGIBILITY CRITERIA & PARTICIPATION PROCESS

Patients interested in participating in our clinical trials must meet specific eligibility criteria based on their diagnosis, treatment history, and genetic markers. Our streamlined process includes:

1. Initial Screening: Patients undergo genetic testing and medical evaluation.

2. Trial Matching: AI algorithms match patients with the most suitable clinical trial.

3. Enrollment & Treatment: Participants receive cutting-edge therapies under expert supervision.

4. Monitoring & Follow-Up: Continuous tracking of treatment effectiveness and patient well-being.

SUCCESS STORIES & PUBLISHED RESEARCH

Our groundbreaking research has led to life-changing results for patients worldwide. Some of our key achievements include:

• Successful remission in leukemia patients treated with AI-identified drugs

• Breakthrough findings in CRISPR-based cancer therapies

• Published research in leading medical journals highlighting the impact of AI and genomic analysis in oncology

At Viventis, we are dedicated to advancing cancer research and treatment through innovation, collaboration, and cutting-edge technology. Join us in our mission to revolutionize oncology.